Nomir Medical Announces Second FDA 510(k) Clearance Of Its Noveon(R) Dual-Wavelength Device

Nomir Medical Technologies, a leader in the development of optical energy technologies for medical applications, announced that the Food and Drug Administration (FDA) has granted a second clearance of the Company’s advanced Noveon® system. With this clearance, the device may now be utilized during procedures of the skin, subcutaneous tissues and nasal passages, for applications in podiatry, dermatology, plastic surgery, and otolaryngology.

More: continued here

Filed under: MRSA / Drug Resistance on January 16th, 2009